In The News
Featured
Explore What's Happening
; SIO 2023 is here! Don’t miss this opportunity to learn more about the latest research in tumor embolization. Check out the Discovery Theater session presented by Dr. Stephen Hunt on Sunday, January 22,2023 at 1:30 pm EST. #interventionalradiology #interventionaloncology
@Instylla Announces Enrollment of Initial Patients in the Prospective Multicenter “HALT” Study #innovation #liquidsstopbleeds #clinicaltrials #interventionalradiology https://instylla.com/instylla-announces-enrollment-of-initial-patients-in-the-prospective-multicenter-halt-study/
This year has been snow awesome! Thank you for being on this journey with us. #happyholidays from the #Instylla team.
#happythanksgiving #grateful
October is Liver Cancer Awareness Month. Join #Instylla in learning about symptoms and preventive measures. If you or someone you know is at risk of getting liver cancer, take action by getting timely screening. #LiverCancerAwarenessMonth #LoveYourLiver #OctoberIs4Livers
It was wicked fun when #Instylla experienced the fascinating history of Boston on a bus... boat! #BostonDuckTours #teambuilding
#Instylla congratulates Dr. Gandras et al. for their recently published study in #JVIR. #interventionalradiology #liquidsstopbleeds https://instylla.com/instylla-announces-positive-results-from-preclinical-studies-of-embrace-hydrogel-embolic-system-in-hemorrhage-models/
#Instylla announces positive preclinical results from the first studies of Embrace™ Hydrogel Embolic System for hemorrhage control. #interventionalradiology #liquidsstopbleeds https://www.prnewswire.com/news-releases/instylla-announces-positive-results-from-preclinical-studies-of-embrace-hydrogel-embolic-system-in-hemorrhage-models-301591298.html
#Instylla congratulates Dr. Suvranu Ganguli, recipient of the JVIR 2021 Editor's Certificate for Distinguished Laboratory Investigation award. #JVIR #SIR22BOS #interventionalradiology
#SIR22BOS has arrived! Don’t miss this opportunity to learn more about the latest research in embolization technology. Check out Scientific Session Embolization 1, Room 259 https://cdmcd.co/XGZ8md #Instylla #interventionalradiology #embolization https://instylla.com/
Get ready for #SIR22BOS! #Instylla is excited to share the possibilities of Embrace™ HES as a next-generation liquid embolic! Join us at the Interventional Oncology: Embolization hands-on workshop Sunday, June 12, 3-4:30 pm. https://cdmcd.co/q9nJRy #interventionaloncology
We’ll see you in 10 days! During the #SIR22BOS Interventional Oncology: Embolization workshop (Sunday, June 12, 3-4:30 pm), #Instylla is excited to share the possibilities of Embrace™ HES as a next-generation liquid embolic. https://cdmcd.co/q9nJRy #interventionaloncology
We’ll see you next week in New York City!
From May 19-21, #Instylla is exhibiting at the #GEST2022 embolization conference. We are excited to share the possibilities of Embrace™ HES as a next-generation liquid embolic. Visit us at Booth 605! #interventionalradiology #IRad
We’ll see you next month! From May 19-21, Instylla is exhibiting at the #GEST2022 conference in New York City! We are excited to share the possibilities of Embrace HES as a next-generation liquid embolic. Visit us at Booth 605! #Instylla #IRad http://www.instylla.com
Instylla thanks Drs. Gerard Goh, Mark Goodwin, Jee-Fu Huang, and Andrew Holden for their collaboration in this #clinicaltrial for the treatment of hypervascular tumors. #embolization #interventionalradiology #cancertreatment https://www.prnewswire.com/news-releases/instylla-first-in-human-clinical-trial-published-results-demonstrate-technical-success-and-persistent-embolization-across-all-patients-301502200.html
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients #clinicaltrial #interventionalradiology #cancertreatment https://www.prnewswire.com/news-releases/instylla-first-in-human-clinical-trial-published-results-demonstrate-technical-success-and-persistent-embolization-across-all-patients-301502200.html?tc=eml_cleartime
Join #Instylla this March in recognizing the thousands of individuals around the globe who are affected by Kidney Cancer. Learn more about maintaining kidney health and how to contribute to the fight against Kidney Cancer at http://kidneycancer.org. #unstoppabletogether
M2D2 #200KChallenge Keynote Speaker: Amar Sawhney, Chairman & CEO of @instylla
Dr. Sawhney has experience mentoring young #Innovators & creating companies through #MedicalDevice incubators.
Learn more about him & how to enter: https://buff.ly/3qO0rRB
M2D2 is pleased to welcome Amar Sawhney, CEO & Chairman of @instylla this year’s #200KChallenge Keynote Speaker.
He’ll be discussing “Considerations for #Startups in #Medtech #Innovation.” Learn more about Dr. Sawhney & how to enter the challenge: https://buff.ly/3qO0rRB
We reflect on all our experiences as this year winds to a close. Thank you for being on this journey with us. Happy holidays from the @instylla family. We look forward to a wonderful 2022!
